PUBLISHER: TechSci Research | PRODUCT CODE: 1785319
PUBLISHER: TechSci Research | PRODUCT CODE: 1785319
Pathogen Reduction Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Product, By End User, By Region & Competition, 2020-2030F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
Global Pathogen Reduction Systems Market was valued at USD 719.06 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.00% through 2030. Pathogens are harmful microorganisms capable of causing serious infections and diseases in the human body. To mitigate the risk of transmitting infections during transfusions, a pathogen reduction system is utilized. This system includes a range of processes and technologies designed to inactivate or remove pathogens from blood and blood products such as plasma, red blood cells, and platelets. Ensuring the safety of these products is especially critical when transfusing patients with weakened immune systems, as contaminated blood could trigger adverse immune responses or lead to further complications.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 719.06 Million |
| Market Size 2030 | USD 1131.99 Million |
| CAGR 2025-2030 | 8.00% |
| Fastest Growing Segment | Platelet Pathogen Reduction |
| Largest Market | North America |
The main goal of pathogen reduction is to enhance the safety of the blood supply by minimizing the risk of transfusion-transmitted infections. Several advanced methods are employed to achieve this. Among them, ultraviolet (UV) light and photochemical treatments are widely used. These techniques work by damaging the nucleic acids (DNA or RNA) of pathogens, effectively preventing them from replicating and causing harm. Photochemical treatments often involve adding a photosensitive compound to the blood product, which, when exposed to UV light, interacts with the pathogen's genetic material, rendering it non-functional. In addition to UV-based technologies, filtration methods also play a key role in pathogen reduction. These involve passing blood through specialized bacterial filters designed with pore sizes small enough to physically block pathogens while allowing essential blood components to pass through. Together, these methods help ensure that transfused blood is as safe and pathogen-free as possible. By implementing pathogen reduction technologies, healthcare systems can significantly reduce the risk of disease transmission during transfusion, thereby safeguarding patient health and improving outcomes, especially for immunocompromised individuals.
Key Market Drivers
Increasing Awareness and Emphasis on Infection Control
Increasing awareness and emphasis on infection control have a significant influence on the growth of the global pathogen reduction systems market. As awareness about the risks and consequences of infections grows, there is a higher demand for effective infection control solutions. For instance, on June 2025, Cerus Corporation (NASDAQ:CERS) participated in the Goldman Sachs 46th Annual Global Healthcare Conference. CEO Obi Greenman highlighted the company's strategic focus on pathogen reduction technologies and the growing adoption of its INTERCEPT blood system. Despite a solid financial foundation and market leadership, Cerus continues to navigate challenges related to expanding market penetration and securing regulatory approvals. Pathogen reduction systems are essential tools in combating the spread of infections in various settings, including healthcare facilities, food processing industries, and public spaces. The emphasis on infection control drives the adoption of these systems, resulting in market growth. Governments and regulatory bodies worldwide have implemented stringent standards and guidelines related to infection control. Compliance with these regulations necessitates the use of pathogen reduction systems in various industries. The awareness of these requirements drives organizations to invest in and implement these systems to ensure compliance and maintain public health and safety. HAIs pose a significant risk to patients, healthcare providers, and the healthcare system as a whole. Increasing awareness of the prevalence and impact of HAIs has led to a greater emphasis on infection control in healthcare settings. Pathogen reduction systems play a crucial role in minimizing the risk of HAIs by eliminating or reducing the presence of pathogens. The focus on infection control in healthcare drives the demand for these systems. Outbreaks of infectious diseases, such as the COVID-19 pandemic, have highlighted the critical importance of infection control and prevention. Governments, healthcare organizations, and other institutions are now prioritizing the preparedness and response to such outbreaks. Pathogen reduction systems are considered essential tools in mitigating the spread of diseases during outbreaks, resulting in increased adoption and market growth. Consumers are becoming more conscious of the risks associated with infections, especially in the context of food safety and public spaces. They expect businesses and establishments to prioritize infection control measures and provide safe environments. This consumer awareness and expectation drive the demand for pathogen reduction systems in industries such as food processing, hospitality, and public facilities. Increased awareness of the importance of infection control has led to collaborative efforts among governments, healthcare organizations, and educational institutions to educate the public about best practices. These initiatives raise awareness about the role of pathogen reduction systems and their effectiveness in preventing the spread of infections. As a result, there is greater acceptance and adoption of these systems, contributing to market growth.
Key Market Challenges
Technological Complexity and Cost
Developing and implementing effective pathogen reduction technologies can be complex and costly. The research, development, and testing of these systems require significant resources, which can impact their affordability and accessibility, especially for small-scale producers. Adhering to strict regulatory standards and guidelines is crucial for pathogen reduction systems, particularly in the food industry. Meeting and maintaining these regulations can be challenging due to evolving standards and variations in requirements across different regions and countries. Introducing new pathogen reduction methods can sometimes face resistance from consumers who might be concerned about the impact of these processes on the sensory qualities, nutritional value, or overall safety of the products.
Key Market Trends
Advanced Technologies and Innovation
The pathogen reduction systems market is likely to see continuous advancements in technologies such as nanotechnology, advanced filtration, and new chemical treatments. These innovations could lead to more efficient and targeted pathogen reduction methods. The integration of Internet of Things (IoT) technology and smart sensors could enable real-time monitoring, data collection, and control of pathogen reduction processes. This could enhance system efficiency, reduce waste, and improve response times to potential issues. Pathogen reduction systems could be integrated more seamlessly into global supply chains, ensuring the safety of products as they move across various stages of production, distribution, and consumption.
Key Market Players
- Terumo BCT, Inc.
- Macopharma SA.
- Cerus Corporation.
- AngioDynamics, Inc.
- Octapharma AG.
Report Scope:
In this report, the Global Pathogen Reduction Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Pathogen Reduction Systems Market, By Type:
- Platelet Pathogen Reduction
- Plasma Pathogen Reduction
Pathogen Reduction Systems Market, By Application:
- Viruses
- Fungi
- Bacteria
Pathogen Reduction Systems Market, By Product:
- Automated
- Semi-Automated
Pathogen Reduction Systems Market, By End User:
- Hospitals & Clinics
- Ambulatory Care centers
- Blood Banks
- Others
Pathogen Reduction Systems Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Pathogen Reduction Systems Market.
Available Customizations:
Global Pathogen Reduction Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pathogen Reduction Systems Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
- 5.2.2. By Application (Viruses, Fungi, Bacteria)
- 5.2.3. By Product (Automated, Semi-Automated)
- 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
- 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 5.2.6. By Company (2024)
- 5.3. Market Map
6. North America Pathogen Reduction Systems Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
- 6.2.2. By Application (Viruses, Fungi, Bacteria)
- 6.2.3. By Product (Automated, Semi-Automated)
- 6.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
- 6.2.5. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Pathogen Reduction Systems Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By Application
- 6.3.1.2.3. By Product
- 6.3.1.2.4. By End User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Pathogen Reduction Systems Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By Application
- 6.3.2.2.3. By Product
- 6.3.2.2.4. By End User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Pathogen Reduction Systems Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By Application
- 6.3.3.2.3. By Product
- 6.3.3.2.4. By End User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Pathogen Reduction Systems Market Outlook
7. Europe Pathogen Reduction Systems Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
- 7.2.2. By Application (Viruses, Fungi, Bacteria)
- 7.2.3. By Product (Automated, Semi-Automated)
- 7.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
- 7.2.5. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Pathogen Reduction Systems Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By Application
- 7.3.1.2.3. By Product
- 7.3.1.2.4. By End User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. Germany Pathogen Reduction Systems Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By Application
- 7.3.2.2.3. By Product
- 7.3.2.2.4. By End User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Pathogen Reduction Systems Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By Application
- 7.3.3.2.3. By Product
- 7.3.3.2.4. By End User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Pathogen Reduction Systems Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By Application
- 7.3.4.2.3. By Product
- 7.3.4.2.4. By End User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Pathogen Reduction Systems Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By Application
- 7.3.5.2.3. By Product
- 7.3.5.2.4. By End User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. France Pathogen Reduction Systems Market Outlook
8. Asia-Pacific Pathogen Reduction Systems Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
- 8.2.2. By Application (Viruses, Fungi, Bacteria)
- 8.2.3. By Product (Automated, Semi-Automated)
- 8.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
- 8.2.5. By Country
- 8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Pathogen Reduction Systems Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By Application
- 8.3.1.2.3. By Product
- 8.3.1.2.4. By End User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Pathogen Reduction Systems Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By Application
- 8.3.2.2.3. By Product
- 8.3.2.2.4. By End User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Pathogen Reduction Systems Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By Application
- 8.3.3.2.3. By Product
- 8.3.3.2.4. By End User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Pathogen Reduction Systems Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By Application
- 8.3.4.2.3. By Product
- 8.3.4.2.4. By End User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Pathogen Reduction Systems Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By Application
- 8.3.5.2.3. By Product
- 8.3.5.2.4. By End User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Pathogen Reduction Systems Market Outlook
9. South America Pathogen Reduction Systems Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
- 9.2.2. By Application (Viruses, Fungi, Bacteria)
- 9.2.3. By Product (Automated, Semi-Automated)
- 9.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
- 9.2.5. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Pathogen Reduction Systems Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By Application
- 9.3.1.2.3. By Product
- 9.3.1.2.4. By End User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. Argentina Pathogen Reduction Systems Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By Application
- 9.3.2.2.3. By Product
- 9.3.2.2.4. By End User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. Colombia Pathogen Reduction Systems Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By Application
- 9.3.3.2.3. By Product
- 9.3.3.2.4. By End User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Brazil Pathogen Reduction Systems Market Outlook
10. Middle East and Africa Pathogen Reduction Systems Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type (Platelet Pathogen Reduction, Plasma Pathogen Reduction)
- 10.2.2. By Application (Viruses, Fungi, Bacteria)
- 10.2.3. By Product (Automated, Semi-Automated)
- 10.2.4. By End User (Hospitals & Clinics, Ambulatory Care centers, Blood Banks, Others)
- 10.2.5. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Pathogen Reduction Systems Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By Application
- 10.3.1.2.3. By Product
- 10.3.1.2.4. By End User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Saudi Arabia Pathogen Reduction Systems Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By Application
- 10.3.2.2.3. By Product
- 10.3.2.2.4. By End User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. UAE Pathogen Reduction Systems Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By Application
- 10.3.3.2.3. By Product
- 10.3.3.2.4. By End User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. South Africa Pathogen Reduction Systems Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Recent Development
- 12.2. Mergers & Acquisitions
- 12.3. Product Launches
13. Global Pathogen Reduction Systems Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
15.1 Terumo BCT, Inc.
15.2 Macopharma SA.
15.3 Cerus Corporation.
15.4 AngioDynamics, Inc.
15.5 Octapharma AG.
16. Strategic Recommendations
17. About Us & Disclaimer
